 VolitionRx NYSE-A:VNRX Limited said its Nu.Q NETs test has been CE marked for the detection and evaluation of NETosis, enabling clinical use in over 27 countries across Europe. NETosis is a unique form of cell death characterized by the release of neutrophil extracellular traps, composed of decondensed chromatin, that trap and kill bacteria and viral particles. 